Ret Proto-Oncogene Antikörper (AA 361-458)
Kurzübersicht für Ret Proto-Oncogene Antikörper (AA 361-458) (ABIN1930190)
Target
Alle Ret Proto-Oncogene (RET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 361-458
-
Spezifität
- Human RET
-
Aufreinigung
- Purified from ascites by Protein A
-
Immunogen
-
RET (AAH03072, aa361-458 partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Type of Immunogen: GST fusion protein -
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC, IHC-P (10 μg/mL), WB
Usage: Sandwich ELISA: Recombinant protein. Western Blot: Recombinant protein. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
-
-
- Ret Proto-Oncogene (RET)
-
Andere Bezeichnung
- RET
-
Hintergrund
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 -
Gen-ID
- 5979
-
Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-